AMANDA TAYLOR: Open Payments
NPI 1063521623 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,782 in 92 payments from 14 companies in 2025. Trend: 2023 $1,392 · 2024 $1,820 · 2025 $1,782
Food & beverage: $1,782
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 55 | $852 |
| Novo Nordisk Inc | 13 | $405 |
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| Lilly USA, LLC | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Viatris Specialty LLC | 2 | $30 |
| BeOne Medicines USA, Inc. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
Products named: QULIPTA, Wegovy, VRAYLAR, UBRELVY, AIRSUPRA, Ozempic, MOUNJARO, CAPLYTA.
Industry payments across NC — which companies pay providers there.
